PAPER Fellgiebel A, Yakushev I
SEARCH RESULTS
330988 RESULTS
PAPER Shu N, Wang Z, Qi Z, Li K, He Y
Multiple diffusion indices reveals white matter degeneration in Alzheimer's disease and mild cognitive impairment: a tract-based spatial statistics study.
J Alzheimers Dis. 2011;26 Suppl 3:275-85. PubMed: 21971467PAPER Canu E, McLaren DG, Fitzgerald ME, Bendlin BB, Zoccatelli G, Alessandrini F, Pizzini FB, Ricciardi GK, Beltramello A, Johnson SC, Frisoni GB
Mapping the structural brain changes in Alzheimer's disease: the independent contribution of two imaging modalities.
J Alzheimers Dis. 2011;26 Suppl 3:263-74. PubMed: 21971466PAPER Oishi K, Mielke MM, Albert M, Lyketsos CG, Mori S
DTI analyses and clinical applications in Alzheimer's disease.
J Alzheimers Dis. 2011;26 Suppl 3:287-96. PubMed: 21971468PAPER Yassa MA
Searching for novel biomarkers using high resolution diffusion tensor imaging.
J Alzheimers Dis. 2011;26 Suppl 3:297-305. PubMed: 21971469PAPER Westman E, Wahlund LO, Foy C, Poppe M, Cooper A, Murphy D, Spenger C, Lovestone S, Simmons A
Magnetic resonance imaging and magnetic resonance spectroscopy for detection of early Alzheimer's disease.
J Alzheimers Dis. 2011;26 Suppl 3:307-19. PubMed: 21971470PAPER Reiman EM, Langbaum JB, Fleisher AS, Caselli RJ, Chen K, Ayutyanont N, Quiroz YT, Kosik KS, Lopera F, Tariot PN
Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments.
J Alzheimers Dis. 2011;26 Suppl 3:321-9. PubMed: 21971471PAPER Förster S, Buschert VC, Teipel SJ, Friese U, Buchholz HG, Drzezga A, Hampel H, Bartenstein P, Buerger K
Effects of a 6-month cognitive intervention on brain metabolism in patients with amnestic MCI and mild Alzheimer's disease.
J Alzheimers Dis. 2011;26 Suppl 3:337-48. PubMed: 21971473PAPER Zhang N, Song X, Zhang Y, Chen W, D'Arcy RC, Darvesh S, Fisk JD, Rockwood K,
An MRI brain atrophy and lesion index to assess the progression of structural changes in Alzheimer's disease, mild cognitive impairment, and normal aging: a follow-up study.
J Alzheimers Dis. 2011;26 Suppl 3:359-67. PubMed: 21971475PAPER Gao FQ, Swartz RH, Scheltens P, Leibovitch FS, Kiss A, Honjo K, Black SE
Complexity of MRI white matter hyperintensity assessments in relation to cognition in aging and dementia from the Sunnybrook Dementia Study.
J Alzheimers Dis. 2011;26 Suppl 3:379-88. PubMed: 21971477PAPER
Upcoming meetings related to Alzheimer's disease.
Neurobiol Dis. 2011 Oct 25; PubMed: 21971500PAPER Furney SJ, Kronenberg D, Simmons A, Güntert A, Dobson RJ, Proitsi P, Wahlund LO, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Spenger C, Lovestone S
Combinatorial markers of mild cognitive impairment conversion to Alzheimer's disease--cytokines and MRI measures together predict disease progression.
J Alzheimers Dis. 2011;26 Suppl 3:395-405. PubMed: 21971479PAPER Rocha NP, Teixeira AL, Coelho FM, Caramelli P, Guimarães HC, Barbosa IG, da Silva TA, Mukhamedyarov MA, Zefirov AL, Rizvanov AA, Kiyasov AP, Vieira LB, Janka Z, Palotás A, Reis HJ
Peripheral blood mono-nuclear cells derived from Alzheimer's disease patients show elevated baseline levels of secreted cytokines but resist stimulation with β-amyloid peptide.
Mol Cell Neurosci. 2012 Jan;49(1):77-84. PubMed: 21971579PAPER Howlett DR
APP transgenic mice and their application to drug discovery.
Histol Histopathol. 2011 Dec;26(12):1611-32. PubMed: 21972099PAPER Viggars AP, Wharton SB, Simpson JE, Matthews FE, Brayne C, Savva GM, Garwood C, Drew D, Shaw PJ, Ince PG
Alterations in the blood brain barrier in ageing cerebral cortex in relationship to Alzheimer-type pathology: a study in the MRC-CFAS population neuropathology cohort.
Neurosci Lett. 2011 Nov 7;505(1):25-30. PubMed: 21970975Current Filters
No filters selected